124
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

A DFT Study of the Reaction between Benzopyrene Epoxide and C60 Derivatives as Possible Anticancer Activity

, &
Pages 593-603 | Received 02 Nov 2018, Accepted 09 Apr 2019, Published online: 16 May 2019
 

Abstract

Benzo (α) pyrene (Bap) is one of the well-known compounds which forming covalent DNA and leads to carcinogenic activity. The [2 + 2] cycloaddition reaction of the benzopyrene epoxide (BaPe) with fullerene could prohibit the initiation of the mutagenic process. This reaction was theoretically studied using the density functional theory method. The functionalization of the C60 with the chemical groups such as OH, COOH, CONH2, and CH2OH caused its activity, solubility, and aromaticity to increase. Both cases of the chemical groups being adjacent to and farthest from the reaction site of the fullerenes and BaPe were considered. The reactions were investigated from the viewpoint of quantum molecular descriptors and thermodynamic quantities of the reaction. The results showed that the reaction between BaPe and C60CONH2 near to CONH2 with the energy of −16.35 kcal/mol was the most suitable reaction. It was concluded that it would be possible to produce novel species for bio-medical applications by attaching the selected chemical groups.

Additional information

Funding

The authors are grateful to the University of Kashan for supporting this work by Grant No. 682229. H. Behzadi also thanks the Kharazmi University for financial support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.